HIGHLIGHTS
- who: Caroline P. Kerr and collaborators from the Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA have published the paper: Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment, in the Journal: Pharmaceutics 2023, 15, 128. of /2023/
- what: The promise of TRT in treatment of metastatic disease and an evolving understanding of the immunogenicity of radiation has led to preclinical and clinical investigations of combination TRT and immunotherapy treatments, which the authors aim to explore here.
- future: In the murine adenocarcinoma MC38 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.